RDA U.K. Ltd Competitors

We are an international, integrated consultancy of engineers,designersand advisers. For over 45 years, we have built an unrivalled reputation by delivering creative, value-led solutions for the benefit of people, places and planet. Described by our clients as 'passionate', 'innovative' and 'collaborative', Buro Happold is synonymouswith the delivery of exceptionally complex projects on every continent, working with the world's leading architectural practices and organisations, such as the United Nations, UNESCO and C40 Cities. Through our global community of driven, world-leading engineering, advisory and design professionals, we are acting to address major challenges in an ever-evolving world.

RES is the world’s largest independent renewable energy company, working across 24 countries and active in wind, solar, energy storage, green hydrogen, transmission, and distribution. An industry innovator for over 40 years, RES has delivered more than 29 GW of renewable energy projects across the globe and plans to bring more than 26 GW of new capacity online in the next five years. As a service provider, RES has the skills and experience in asset management, operations and maintenance (O&M), and spare parts – supporting 45 GW of renewable assets across 1,300 sites. RES brings to the market a range of purposeful, practical technology-based products and digital solutions designed to maximise investment and deployment of renewable energy. RES is the power behind a clean energy future where everyone has access to affordable zero carbon energy bringing together global experience, passion, and the innovation of its 4,500 people to transform the way energy is generated, stored and supplied.

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.